Staff superheroes
It’s a bird. It’s a plane. It’s a window washer! Dressed as a superhero to clean and brighten your day.

Crohn's disease is an inflammatory bowel disease (IBD). IBD is a general term for noninfectious conditions that involve chronic inflammation of the intestines, causing symptoms such as diarrhea, abdominal pain, fevers, bleeding and growth problems.
Ulcerative colitis is another kind of IBD, as is a more unusual form called microscopic colitis. Although Crohn's disease and ulcerative colitis are often difficult to distinguish from each other because they have many of the same symptoms, they affect the digestive tract differently.
Crohn's disease can involve any part of the digestive tract from the mouth to the anus, while ulcerative colitis is limited to the colon. In more than half of children with Crohn's disease, what's affected is the last part of the small intestine (the ileum) as well as the first part or much of the large intestine, colon and rectum. The inflammation also extends deeper into the lining of the intestinal wall in Crohn's disease than it does in ulcerative colitis.
About a third of children with Crohn's disease have external problems around their bottom, called perianal disease. Any child with a skin tag, fissure (tear) or abscess in the anal area should be evaluated for the disease.
About 25 percent of IBD cases begin in childhood, even in children under age 2. Diagnosis is often delayed because IBD is confused with other conditions, such as lactose intolerance, a stomach virus or school avoidance behavior.
Crohn's disease may relapse and then recur at various points in the patient's lifetime, with periods of symptom-free remission. There's no consistently accurate way to predict when remission will occur or when symptoms will return.
In some families, the condition is inherited. About 20 to 25 percent of people — and up to 40 percent of very young children — with Crohn's disease have a close relative with ulcerative colitis or Crohn's disease. The immune system's response to certain bacteria in the gut and the patient's genetic makeup are believed to be the primary causes.
In UCSF's IBD Program, a medical team of doctors, nurse practitioners, dietitians, social workers and other consultants — including pediatric experts in psychology and psychiatry, infectious diseases, rheumatology, dermatology, ophthalmology and surgery — work together to provide your child and family with optimal and state-of-the-art care. Please feel free to request information about our program at any time.
Common symptoms of Crohn's disease include:
During periods of active symptoms, your child may also experience:
Because chronic diarrhea and inflammation can reduce the amount of nutrients absorbed from food, some children with Crohn's disease have stunted growth and delayed development.
Your child's doctor will first do a physical examination and take a medical history. There's no single test for diagnosing Crohn's disease, so if the doctor suspects Crohn's, a series of tests is required to make a definitive diagnosis. Tests may include:
Although there's no cure for Crohn's disease, treatments are available.
Medications are used to suppress the inflammation associated with Crohn's disease. This helps the intestines heal, relieving symptoms and possibly preventing progression of disease and potential complications. Once symptoms are under control, medications may reduce the frequency of flare-ups (relapses) and prevent symptoms from recurring.
Medications for treating the disease include aminosalicylates, corticosteroids, immunomodulators and biologic therapy.
Nutritional therapies can also help treat or at least support nutrition and growth of children with Crohn's disease. Special formulas can be used as a primary treatment for children in place of some medications. Some newer diets are being tested by our medical team. Or, your child's doctor may recommend nutritional supplements.
A small number of patients need to be fed by tube through the nose or intravenously from time to time. This can help those who temporarily need extra nutrition, who can't eat enough, whose intestines need to rest, or who can't absorb enough nutrition from food.
You can discuss all these options with your medical team, including a dietitian familiar with the treatment of Crohn's disease.
Surgery may be suggested when medications are no longer effective. Typically, surgery removes the diseased part of the bowel and then joins the two healthy ends of the bowel together.
Another surgical option is an ileostomy. In this procedure, the surgeon creates a small opening in the abdomen — about the size of a quarter — and attaches it to the ileum (the end of the small intestine). Waste can then travel through the small intestine and exit the body through the opening and into a pouch. The patient empties the pouch as needed.
Although surgery can provide many symptom-free years, it's not considered a cure because the disease usually recurs. For this reason, doctors aim to avoid surgery or to remove as little as possible of the diseased part of the bowel.
One focus of the UCSF IBD team is to find new and sometimes experimental ways to improve the management and long-term outcomes of our patients, often through multinational research projects. Patients may have the option of participating in research trials of new therapies for IBD.
We also track the progress of almost all our patients to help improve the treatment options and information we can offer future patients.
UCSF Benioff Children's Hospitals medical specialists have reviewed this information. It is for educational purposes only and is not intended to replace the advice of your child's doctor or other health care provider. We encourage you to discuss any questions or concerns you may have with your child's provider.
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
The achievement of complete healing (CH) 52 weeks after initiation of anti-TNF therapy guided by ROADMAB™ (therapeutic drug monitoring) as evidenced by a composite of all of the following four features below: 1. Endoscopic heal...
Recruiting
More about this studyA Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Clinical response based on PCDAI, and endoscopic response based on SES-CD.
Recruiting
More about this studyOne of the nation's best for gastroenterology & GI surgery
Ranked among the nation's best in 11 specialties
Staff superheroes